Literature DB >> 20679734

Volumetric analysis of coronary plaque characterization in patients with metabolic syndrome using 64-slice multi-detector computed tomography.

Kosuke Arai1, Hideki Ishii, Tetsuya Amano, Tadayuki Uetani, Michio Nanki, Nobuyuki Marui, Masataka Kato, Kiminobu Yokoi, Hirohiko Ando, Soichiro Kumagai, Ken Harada, Daiji Yoshikawa, Satoru Ohshima, Tatsuaki Matsubara, Toyoaki Murohara.   

Abstract

BACKGROUND: Metabolic syndrome (MetS) is associated with adverse cardiovascular events and mortality, where acute coronary syndrome significantly impacts on mortality and morbidity. In contrast, evidences have accumulated that the lipid-rich plaque might play a critical role in acute coronary syndrome. METHODS AND
RESULTS: The study population consisted of 94 patients with suspected angina pectoris who underwent multi-detector computed tomography (MDCT). Of those, we identified 41 with MetS. In MDCT analysis, low-density plaque volume (LDPV) (42 ± 28 vs 24 ± 18 mm(3), P=0.0003), moderate-density plaque volume (105 ± 41 vs 82 ± 33 mm(3), P=0.003), total plaque volume (164 ± 70 vs 118 ± 59 mm(3), P=0.0008) and %LDPV (24.2 ± 10.0 vs 18.3 ± 7.1%, P=0.01) were significantly increased in the MetS group compared to the non-MetS group. Multivariate linear regression analysis after adjusting for confounding variables revealed that MetS was significantly correlated with an increase in %LDPV (β=0.48, P=0.0001). Multivariate logistic regression analysis for lipid-rich plaque after adjusting for confounding variables indicated that MetS was significantly associated with lipid-rich plaque (odds ratio: 5.99, 95% confidence intervals: 1.94-18.6, P=0.002).
CONCLUSIONS: Patients with MetS were strongly related to having a lipid-rich composition in their coronary plaque, as detected by MDCT.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20679734     DOI: 10.1253/circj.cj-10-0219

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  4 in total

1.  Role of Akt/protein kinase B in the activity of transcriptional coactivator p300.

Authors:  J Chen; S S Halappanavar; J R St-Germain; B K Tsang; Q Li
Journal:  Cell Mol Life Sci       Date:  2004-07       Impact factor: 9.261

2.  Prognostic Value of Metabolic Syndrome in Patients With Non-ST Elevated Myocardial Infarction Undergoing Percutaneous Coronary Intervention.

Authors:  Li-Hong Zhao; Yin Liu; Jian-Yong Xiao; Ji-Xiang Wang; Xiao-Wei Li; Zhuang Cui; Jing Gao
Journal:  Front Cardiovasc Med       Date:  2022-06-23

3.  Impact of metabolic syndrome on myocardial injury and clinical outcome after percutaneous coronary intervention.

Authors:  J Li; S-J Song; J-P Xu; X-Z Zhao; Z-W Xu; X-J Sun; L-F Wang; X-C Yang
Journal:  Herz       Date:  2014-10-26       Impact factor: 1.443

4.  Procoagulant activity of circulating microparticles is associated with the presence of moderate calcified plaque burden detected by multislice computed tomography.

Authors:  Serena Del Turco; Giuseppina Basta; Alessandro Mazzarisi; Debora Battaglia; Teresa Navarra; Michele Coceani; Massimiliano Bianchi; Mathis Schlueter; Paolo Marraccini
Journal:  J Geriatr Cardiol       Date:  2014-03       Impact factor: 3.327

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.